الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

puretek corporation - chromium nicotinate (unii: a150ay412v) (chromic cation - unii:x1n4508kf1), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), vitamin a acetate (unii: 3le3d9d6oy) (vitamin a - unii:81g40h8b0t), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), calcium carbonate (unii: h0g - venexa fe is indicated for the treatment of iron deficiency anemia and folate deficiency as in extended convalescence, menorrhagia, pregnancy, puberty, excessive blood loss and advanced age. also for treatment of condition in which iron deficiency and vitamin c deficiency occur together, along with a deficient intake or increased need for b-complex vitamins in chronic and acute illness, as well as cases of metabolic stress, and in convalescence. this product is contraindicated in patients with known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. pernicious anemia is a contraindication, as folic acid may obscure its signs and symptoms.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

puretek corporation - chromium nicotinate (unii: a150ay412v) (chromic cation - unii:x1n4508kf1), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), vitamin a acetate (unii: 3le3d9d6oy) (vitamin a - unii:81g40h8b0t), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), calcium carbonate (unii: h0g - ventrixyl™ fe is indicated for the treatment of iron deficiency anemia and folate deficiency as in extended convalescence, menorrhagia, pregnancy, puberty, excessive blood loss, and advanced age. also for the treatment of conditions in which iron deficiency and vitamin c deficiency occur together, along with a deficient intake or increased need for b-complex vitamins in chronic and acute illness, as well as cases of metabolic stress, and in convalescence. this product is contraindicated in patients with known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. pernicious anemia is a contraindication, as folic acid may obscure its signs and symptoms.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

star combo australia pty ltd - ascorbic acid,calcium hydrogen phosphate dihydrate,cyanocobalamin,ferrous fumarate,folic acid,nicotinamide,pyridoxine hydrochloride,riboflavine,thiamine -

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

us pharmaceutical corporation - folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr) - folic acid 1 mg

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

nnodum pharmaceuticals - ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), intrinsic factor (unii: 70bt6oqt2q) (intrinsic factor - unii:70bt6oqt2q), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - ferrous cation 66 mg - for the treatment of all anemias responsive to oral iron therapy, such as hypochromic anemia associated with pregnancy, chronic or acute blood loss, dietary restriction, metabolic disease and post-surgical convalescence. hemochromatosis and hemosiderosis are contraindications to iron therapy.

الفلبين - الإنجليزية - FDA (Food And Drug Administration)

iae pharmaceuticals corp. - ferrous fumarate , folic acid - capsule - 66 mg (equivalent to 200 mg ferrous fumarate) / 250 mcg

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - ferrous fumarate 310mg;  ; folic acid 0.35mg;   - film coated tablet - 310mg/0.35mg - active: ferrous fumarate 310mg   folic acid 0.35mg   excipient: glycerol hypromellose iron oxide red macrogol 400 macrogol 6000 magnesium stearate microcrystalline cellulose povidone purified talc sodium laurilsulfate sodium starch glycolate titanium dioxide - for the prevention and treatment of iron and folic acid deficiency anaemia, including during pregnancy.

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

teofarma s.r.l. - ferrous sulphate; folic acid - prolonged-release tablet - 325 mg/0.35 milligram(s) - iron in combination with folic acid; ferrous sulfate

الفلبين - الإنجليزية - FDA (Food And Drug Administration)

ad-drugstel pharma lab, inc - ferrous sulfate , folic acid - tablet - 186mg/ 400mcg

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

trigen laboratories, llc - ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), iron (unii: e1uol152h7) (iron - unii:e1uol152h7), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), calcium pantothenate (unii: 568et80c3d) (calcium cation - unii - ferrous cation 130 mg - folivane™-ob is contraindicated in patients with known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemia. pernicious anemia is a contraindication, as folic acid may obscure its signs and symptoms.